GAMCO Investors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

GAMCO Investors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,558	Closed	-$1.85M	–	937
2022 Q2	$1.85M	Buy	+24,558	New	+$1.09M	0.02%	488

GAMCO Investors's TPTX Position: Q3 2022 in Review

GAMCO Investors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 24,558 shares — an estimated $1.85M sold.

GAMCO Investors first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1.85M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

GAMCO Investors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
GAMCO Investors sold 24,558 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.85M.
GAMCO Investors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
GAMCO Investors's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.85M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on GAMCO Investors's 13F filing for Q3 2022, filed 10 Nov 2022.